Conduit Pharmaceuticals Stock Forward View - Simple Moving Average
| CDT Stock | 0.49 0.01 2.08% |
The Simple Moving Average forecast reference data for Conduit Pharmaceuticals is based on the equity's recent trading history. This page summarizes the model output and key accuracy metrics for reference.
The Simple Moving Average forecasted value of Conduit Pharmaceuticals on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 3.92.The simple moving average model is conceptually a linear regression of the current value of Conduit Pharmaceuticals price series against current and previous (unobserved) value of Conduit Pharmaceuticals. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future All Simple Moving Average forecast figures shown for Conduit Pharmaceuticals are reference data reflecting model output based on available historical prices. Simple Moving Average Price Forecast For the 22nd of March
Given 90 days horizon, the Simple Moving Average forecasted value of Conduit Pharmaceuticals on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.07 , mean absolute percentage error of 0.01 , and the sum of the absolute errors of 3.92 .Please note that although there have been many attempts to predict Conduit Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Conduit Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Conduit Pharmaceuticals | Conduit Pharmaceuticals Price Prediction | Research Analysis |
Forecasted Value
For the next trading day, Macroaxis evaluates Conduit Pharmaceuticals' predictive range by looking for statistically meaningful downside and upside boundaries. At the moment, the model places downside around 0.0049 and upside around 7.82 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Conduit Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Conduit Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.3801 |
| Bias | Arithmetic mean of the errors | 0.028 |
| MAD | Mean absolute deviation | 0.0653 |
| MAPE | Mean absolute percentage error | 0.0675 |
| SAE | Sum of the absolute errors | 3.92 |
Other Forecasting Options for Conduit Pharmaceuticals
Whether a novice or experienced investor, anyone considering Conduit needs to understand the dynamics of Conduit Pharmaceuticals' price movement. Price charts for Conduit Stock contain a significant amount of noise that can distort investment decisions.Conduit Pharmaceuticals Related Equities
The following equities are related to Conduit Pharmaceuticals within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Conduit Pharmaceuticals against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Conduit Pharmaceuticals Market Strength Events
Analyzing market strength indicators for Conduit Pharmaceuticals enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Conduit Pharmaceuticals.
| Accumulation Distribution | 8840.82 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 0.47 | |||
| Day Typical Price | 0.47 | |||
| Price Action Indicator | 0.03 | |||
| Period Momentum Indicator | 0.01 |
Conduit Pharmaceuticals Risk Indicators
Identifying and analyzing Conduit Pharmaceuticals' key risk indicators is a foundational step in projecting how its price may evolve. This process quantifies the risk associated with Conduit Pharmaceuticals' and decide how to manage it.
| Mean Deviation | 5.16 | |||
| Standard Deviation | 7.1 | |||
| Variance | 50.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Conduit Pharmaceuticals
Coverage intensity for Conduit Pharmaceuticals matters because narrative visibility can influence sentiment, participation, and volatility around the name. A disciplined read of coverage separates durable relevance from temporary noise.
Contributor Headline
Latest Perspective From Macroaxis
Conduit Pharmaceuticals Short Properties
Short sentiment tied to Conduit Pharmaceuticals matters because heavier bearish pressure can change how quickly future price expectations become unstable. The practical goal is to identify when the balance between long and short participation may be changing the quality of the setup.
| Common Stock Shares Outstanding | 40.2 M | |
| Dividends Paid | 8 M | |
| Cash And Short Term Investments | 389.9 M | |
| Shares Float | 1.4 M |
Additional Tools for Conduit Stock Analysis
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |